Haruo Imawaka

Haruo Imawaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on diketohydrazine derivative compounds. With a total of 3 patents to his name, Imawaka's innovations are paving the way for advancements in medical treatments.

Latest Patents

Imawaka's latest patents focus on diketohydrazine derivative compounds and drugs containing these compounds as active ingredients. The invention relates to a specific diketohydrazine derivative of formula (I) and its pharmaceutically acceptable salts. This compound exhibits inhibitory activity against cysteine protease, making it useful for treating a variety of conditions, including inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, neuronal diseases, hepatic or biliary diseases, osseous or articular diseases, and metabolic diseases. Additionally, the compound has shown inhibitory activity against elastase, which is beneficial for the treatment of chronic obstructive pulmonary disease (COPD).

Career Highlights

Haruo Imawaka is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of complex diseases.

Collaborations

Imawaka has collaborated with esteemed colleagues such as Akira Hatayama and Hiroshi Tsuruta, contributing to a dynamic research environment that fosters innovation.

Conclusion

Haruo Imawaka's contributions to the field of pharmaceuticals through his patented diketohydrazine derivative compounds highlight his role as a significant inventor. His work not only advances medical science but also offers hope for effective treatments for various diseases.